CLINICAL_TRIALS
trial_result
· 2009-10-01
Clinical Trial Update: E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Phase 3]
Summary
Phase 3 trial evaluating the efficacy and safety of 10 mg rabeprazole for treating heartburn in frequent sufferers has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Heartburn | Phase 3 | Status: COMPLETED | Results posted: 2009-10-01